Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant — with cells from their own blood — two-thirds saw no worsening in their disability 10 years out. That… read on > read on >
THURSDAY, Jan. 21, 2021 (HealthDay News) – – With rising obesity rates, more young women American women are developing type 2 diabetes, putting them at hugely increased risk for heart disease, new research shows. In fact, the study found that women under 55 with type 2 diabetes had a tenfold greater risk of having heart… read on > read on >
Despite scattered media reports of severe allergic reactions to the Pfizer COVID-19 vaccine, a detailed analysis shows that such incidents are very rare, striking just 11 people for every million doses given. The study, compiled by researchers at the U.S. Centers for Disease Control and Prevention, also found that episodes of severe allergic reaction —… read on > read on >
A day after his inauguration, President Joe Biden plans to unveil a new, far-reaching pandemic response plan. He’ll also issue executive orders that aim to ramp up the production and distribution of COVID-19 tests and vaccines, make schools and travel safer, and help states fight the spread of coronavirus. “We’ll press forward with speed and… read on > read on >
U.S. President Joe Biden has promised to re-energize the nation’s response to COVID-19, but one of his top pandemic advisors says that effort could be hamstrung by both the virus and the failings of the previous administration. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, said… read on > read on >
The arthritis drug tocilizumab doesn’t help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery. In fact, patients receiving tocilizumab had a higher risk of death, so the trial was halted early. Tocilizumab blocks a part of the immune system (interleukin 6) that can… read on > read on >
While children are less susceptible to illness with the new coronavirus, they are nearly 60% more likely than adults over 60 to infect other family members when they are sick, a new study shows. The findings show the need to conduct COVID-19 vaccine safety and efficacy studies in children, according to co-senior study author Yang… read on > read on >
You may think that cats crave the plants catnip and silver vine because it makes them feel euphoric, and that’s true. Yet new research indicates felines also use the plants for another key reason: to keep mosquitoes at bay. Silver vine, a catnip alternative, grows in China and Japan. Researchers began by identifying that one… read on > read on >
Just over 200,000 Americans have the autoimmune disorder lupus, and minority women are at highest risk, according to a new study. It’s the first estimate of how widespread the disease is in the United States. The number comes close to reclassifying lupus as a rare disease, defined as an illness affecting 200,000 Americans or fewer,… read on > read on >
Menopause is known to bring a variety of unpleasant symptoms ranging from hot flashes to insomnia. Yet, for those who have a condition known as premature ovarian insufficiency (POI), it is much worse, researchers report. The new study examined the impact of POI, in which ovarian function stops and leads to menopause before the age… read on >
